Antigen Specificity Enhances Disease Control by Tregs in Vitiligo

Simple item page
dc.contributor.authoret al.
dc.contributor.authorJoseph F. Haughney
dc.contributor.authorAbigail C. Overacre-Delgoffe
dc.contributor.authorVictor H. H. Engelhard
dc.contributor.authorVictor H. H. Engelhard
dc.date.accessioned2025-08-19T10:36:01Z
dc.date.available2025-08-19T10:36:01Z
dc.date.issued2023-01-01
dc.description.abstractTregs engineered to express a TCR specific to melanocyte antigens provide superior disease control in a mouse model of vitiligo, homing to skin, persisting long-term, and suppressing effector T cells more effectively than polyclonal Tregs.en
dc.identifier.citationEngelhard, V. H. H.; Overacre-Delgoffe, A. C.; Haughney, J. F.; et al. (2023). Antigen Specificity Enhances Disease Control by Tregs in Vitiligo. Science Translational Medicine, 15(691), eabn2748. https://doi.org/10.1126/scitranslmed.abn2748en
dc.identifier.doi10.1126/scitranslmed.abn2748
dc.identifier.otherFilename:Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.pdf
dc.identifier.urihttps://doi.org/10.1126/scitranslmed.abn2748
dc.identifier.urihttps://nur.nu.edu.kz/handle/123456789/9582
dc.language.isoen
dc.publisherAAAS
dc.relation.ispartofScience Translational Medicineen
dc.sourceScience Translational Medicine, 15(691), eabn2748, (2023)en
dc.subjecttype of access: open accessen
dc.subjectautoimmunityen
dc.subjectantigen specificityen
dc.subjectimmune toleranceen
dc.subjectvitiligoen
dc.subjectTregsen
dc.subjectTregsen
dc.titleAntigen Specificity Enhances Disease Control by Tregs in Vitiligoen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.pdf
Size:
16.02 MB
Format:
Adobe Portable Document Format
Download

Collections

Articles